KUREvsETF 2ETF Comparison
ETF 1
KURE
KraneShares MSCI All China Health Care Index ETF
This fund is part of
China Blended Cap
-0.24%
VS
Choose a second ETF to run a side-by-side ETF comparison with KURE, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
KURE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/30/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | KURE ETF 2 | -9.54%– | +2.04%– | +2.21%– | -3.71%– | +0.48%– | -38.67%– |
| Flows | KURE ETF 2 | +$5M– | +$8M– | +$29M– | +$16M– | +$39M– | -$12M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | KURE ETF 2 | +28.90%– | +28.05%– | +26.82%– | +27.55%– |
| Max drawdown | KURE ETF 2 | -10.67%– | -24.36%– | -31.17%– | -58.52%– |
| Max drawdown duration | KURE ETF 2 | 24d– | 259d– | 619d– | 1804d– |
Trading data
KURE | ETF 2 | |
Last sale 10/30/2026 at 1:30 PM | $17.62 | – |
| Previous close 10/29/2026 | $17.80 | – |
| Consolidated volume 10/29/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
KURE | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
KURE | ETF 2 | |
|---|---|---|
| Last price | $17.62 | – |
| 1D performance | -1.01% | – |
| AuM | $107.87 M | – |
| E/R | 0.79% | – |
Characteristics
KURE | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | KraneShares | – |
| Benchmark | MSCI China All Shares Health Care 10/40 Index | – |
| N° of holdings | 40 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 31, 2018 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
KURE
China
82.88%
Switzerland
8.83%
Hong Kong
7.35%
Other
0.94%
ETF 2
Sectors
KURE
Healthcare
98.18%
Other
1.82%
ETF 2
Advertisement
Diversification
KURE
Total weight of top 15 holdings out of 15
68.44%
ETF 2
–
Top 15 holdings
Data as of September 30, 2026
KURE
BeOne Medicines Ltd.
8.83%
Innovent Biologics, Inc.
8.56%
WuXi Biologics (Cayman), Inc.
8.05%
WuXi AppTec Co., Ltd.
5.79%
Akeso, Inc.
4.67%
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
4.46%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
4.37%
CSPC Pharmaceutical Group Ltd.
3.77%
Sino Biopharmaceutical Ltd.
3.74%
Genscript Biotech Corp.
3.61%
WuXi AppTec Co., Ltd.
3.36%
Hansoh Pharmaceutical Group Co., Ltd.
2.93%
3SBio, Inc.
2.11%
Yunnan Baiyao Group Co., Ltd.
2.11%
Shanghai United Imaging Healthcare Co., Ltd.
2.08%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
